[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3968 Introduced in House (IH)]

<DOC>






114th CONGRESS
  1st Session
                                H. R. 3968

To amend the Controlled Substances Act to allow the Attorney General to 
  exempt a product from certain requirements if the Attorney General 
 determines that it is not practical by processes known to be employed 
 by clandestine laboratory operators to use the product in the illicit 
                    manufacture of methamphetamine.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            November 5, 2015

  Mr. Guinta introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to allow the Attorney General to 
  exempt a product from certain requirements if the Attorney General 
 determines that it is not practical by processes known to be employed 
 by clandestine laboratory operators to use the product in the illicit 
                    manufacture of methamphetamine.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Meth Labs and Enhance Patient 
Access Act of 2015''.

SEC. 2. EXEMPTION FOR PRODUCTS IF IT IS NOT PRACTICAL BY PROCESSES 
              KNOWN TO BE EMPLOYED BY CLANDESTINE LABORATORY OPERATORS 
              TO USE THE PRODUCTS IN THE ILLICIT MANUFACTURE OF 
              METHAMPHETAMINE.

    Section 310(e)(3) of the Controlled Substances Act (21 U.S.C. 
830(e)(3)) is amended by striking ``if the Attorney General determines 
that the product cannot be used in the illicit manufacture of 
methamphetamine'' and inserting ``if the Attorney General determines 
that it is not practical by processes known to be employed by 
clandestine laboratory operators to use the product in the illicit 
manufacture of methamphetamine''.
                                 <all>